JPS5622730A - Treatment for eye vascularization - Google Patents

Treatment for eye vascularization

Info

Publication number
JPS5622730A
JPS5622730A JP9578180A JP9578180A JPS5622730A JP S5622730 A JPS5622730 A JP S5622730A JP 9578180 A JP9578180 A JP 9578180A JP 9578180 A JP9578180 A JP 9578180A JP S5622730 A JPS5622730 A JP S5622730A
Authority
JP
Japan
Prior art keywords
treatment
vascularization
eye
eye vascularization
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP9578180A
Other languages
English (en)
Other versions
JPH0114204B2 (ja
Inventor
Ee Kuupaa Chiyaaruzu
Bui Daburiyuu Berugami Maikeru
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Allergan Inc
Original Assignee
Allergan Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allergan Pharmaceuticals Inc filed Critical Allergan Pharmaceuticals Inc
Publication of JPS5622730A publication Critical patent/JPS5622730A/ja
Publication of JPH0114204B2 publication Critical patent/JPH0114204B2/ja
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP9578180A 1979-07-16 1980-07-15 Treatment for eye vascularization Granted JPS5622730A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/057,608 US4230724A (en) 1979-07-16 1979-07-16 Method of treating vascularization of the eye with Flurbiprofen

Publications (2)

Publication Number Publication Date
JPS5622730A true JPS5622730A (en) 1981-03-03
JPH0114204B2 JPH0114204B2 (ja) 1989-03-10

Family

ID=22011655

Family Applications (1)

Application Number Title Priority Date Filing Date
JP9578180A Granted JPS5622730A (en) 1979-07-16 1980-07-15 Treatment for eye vascularization

Country Status (3)

Country Link
US (1) US4230724A (ja)
JP (1) JPS5622730A (ja)
ZA (1) ZA804262B (ja)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5810517A (ja) * 1981-07-13 1983-01-21 Santen Pharmaceut Co Ltd 非ステロイド系消炎剤を主成分とする点眼剤
JPS58126810A (ja) * 1981-12-24 1983-07-28 Kaken Pharmaceut Co Ltd 抗炎症眼科用液剤およびその製法
JPS5929616A (ja) * 1982-08-10 1984-02-16 Kaken Pharmaceut Co Ltd 抗炎症眼科用液剤およびその製法

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2075837B (en) * 1980-05-14 1984-03-14 Hisamitsu Pharmaceutical Co Topical pharmaceutical gel containing anti-inflammatory analgesic agents
US4439451A (en) * 1983-06-30 1984-03-27 The Upjohn Company Treatment of the blood-brain barrier with flurbiprofen
US5171566A (en) * 1986-05-16 1992-12-15 The Green Cross Corporation Flurbiprofen derivative ophthalmic preparation
JP2764261B2 (ja) * 1987-03-17 1998-06-11 リ−ドケミカル株式会社 外用消炎鎮痛剤
US5110493A (en) * 1987-09-11 1992-05-05 Syntex (U.S.A.) Inc. Ophthalmic NSAID formulations containing a quaternary ammonium preservative and a nonionic surfactant
US5414011A (en) * 1987-09-11 1995-05-09 Syntex (U.S.A.) Inc. Preservative system for ophthalmic formulations
US4960799A (en) * 1988-09-13 1990-10-02 Ciba-Geigy Corporation Stabilized aqueous solutions of pharmaceutically acceptable salts of ortho-(2,6-dichlorophenyl)-aminophenylacetic acid for opthalmic use
US5124154A (en) * 1990-06-12 1992-06-23 Insite Vision Incorporated Aminosteroids for ophthalmic use
US5340572A (en) * 1993-02-08 1994-08-23 Insite Vision Incorporated Alkaline ophthalmic suspensions
US5382599A (en) * 1993-10-13 1995-01-17 Allergan, Inc. Method of inhibiting protozoan growth in eye care products using a polyvalent cation chelating agent
AU2002247284A1 (en) 2001-04-02 2002-10-15 Alcon, Inc. Method of treating ocular inflammatory and angiogenesis-related disorders using an amide derivative of flubiprofen or ketorolac
US20030027867A1 (en) * 2001-06-29 2003-02-06 Myriad Genetics, Incorporated Use of R-NSAID compounds for anti-HIV treatment
US20030143165A1 (en) * 2002-01-25 2003-07-31 Allan Evans NSAID-containing topical formulations that demonstrate chemopreventive activity
WO2005049014A1 (en) * 2003-11-18 2005-06-02 Pharmacia Corporation Cox-2 inhibitors for the treatment or prevention of diabetes-related ocular disorders
WO2005102303A2 (en) * 2004-04-21 2005-11-03 Advanced Ocular Systems Limited Antiprostaglandins for the treatment of ocular pathologies
US20070015832A1 (en) * 2005-07-14 2007-01-18 Myriad Genetics, Incorporated Methods of treating overactive bladder and urinary incontinence
US20100130580A1 (en) * 2006-01-25 2010-05-27 Aciex Therapeutics, Inc. Formulations and Methods for Treating Dry Eye
EP1981491A4 (en) * 2006-01-25 2009-09-23 Aciex Inc COMPOSITIONS AND METHODS FOR TREATING OPHTHALMIC DROUGHT
WO2008153746A1 (en) * 2007-05-24 2008-12-18 Aciex Therapeutics, Inc. Formulations and methods for treating dry eye
CN110448530A (zh) * 2018-05-07 2019-11-15 北京蓝丹医药科技有限公司 一种氟比洛芬酯注射液

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1091403A (en) * 1964-01-24 1967-11-15 Boots Pure Drug Co Ltd Therapeutically active phenylalkane derivatives
US3865949A (en) * 1973-08-02 1975-02-11 Upjohn Co Process of treatment
US4009283A (en) * 1973-11-07 1977-02-22 The Upjohn Company Antiinflammatory and antithrombotic compositions and method of use

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
AMERICAN JOURNAL OF OPHTHALMOLOGY=1979 *
INVESTIGATIVE OPHTHALMOLOGY=1976 *
THE KURUME MEDICAL JOURNAL=1979 *

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5810517A (ja) * 1981-07-13 1983-01-21 Santen Pharmaceut Co Ltd 非ステロイド系消炎剤を主成分とする点眼剤
JPH0228573B2 (ja) * 1981-07-13 1990-06-25 Santen Pharma Co Ltd
JPS58126810A (ja) * 1981-12-24 1983-07-28 Kaken Pharmaceut Co Ltd 抗炎症眼科用液剤およびその製法
JPS5929616A (ja) * 1982-08-10 1984-02-16 Kaken Pharmaceut Co Ltd 抗炎症眼科用液剤およびその製法
JPH0330571B2 (ja) * 1982-08-10 1991-04-30

Also Published As

Publication number Publication date
US4230724A (en) 1980-10-28
JPH0114204B2 (ja) 1989-03-10
ZA804262B (en) 1981-08-26

Similar Documents

Publication Publication Date Title
JPS5622730A (en) Treatment for eye vascularization
PH19294A (en) Treatment method
GB2066324B (en) Well treatment apparatus
JPS5666250A (en) Treating device for secretion
GB2056282B (en) Implant device
JPS56103113A (en) Drug for shock treatment
GB2034499B (en) Ophthalmological apparatus
JPS5679199A (en) Composition for textile treatment
GB2052979B (en) Ophthalmological use for colostrum
JPS571323A (en) Ophthalmology apparatus
JPS5654839A (en) Device for treating dentine canaliculus
JPS5692818A (en) Parasiteestuck warmmblooded animal novel treatment
JPS5777010A (en) Sulfur treatment
JPS5663353A (en) Bed for treatment
JPS5618837A (en) Keratometer
JPS568032A (en) Eyeground camera
JPS5675164A (en) Device for treating blood
JPS5683326A (en) Eyeground camera
JPS5596138A (en) Eyeground camera
JPS5651413A (en) Glaucoma treatment
JPS55127980A (en) Tobacco treatment
JPS56151046A (en) Stick for medical treatment
ZA80404B (en) Carpet treatment
JPS55120852A (en) Eyeground camera
JPS55129034A (en) Eyeground camera